CIK 0001638287
- Non-accelerated filer
- Smaller reporting company
MetaVia Inc.
Sign in to watch- Ticker
- MTVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472389984
- Phone
- +1 857-702-9600
- Business address
- 545 CONCORD AVENUE, SUITE 210, CAMBRIDGE, MA, 02138
- Former names
- NeuroBo Pharmaceuticals, Inc., Gemphire Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 19 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-08-10 | MATHIESEN JEFFREY S Chief Financial Officer | Option exercise | +3,000 | $3.59 | $11K | 10,927 |
| 2017-08-10 | MATHIESEN JEFFREY S Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −3,000 | 45,093 | ||
| 2017-08-10 | MATHIESEN JEFFREY S Chief Financial Officer | Option exercise | +3,000 | $3.59 | $11K | 10,927 |
| 2017-08-10 | MATHIESEN JEFFREY S Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −3,000 | 0 | ||
| 2017-07-31 | Bisgaier Charles PhD Chief Scientific Off. & Chair | Option exercise | +4,474 | $1.34 | $6K | 1,248,914 |
| 2017-07-31 | Bisgaier Charles PhD Chief Scientific Off. & Chair | Option exercise · Employee Stock Option (right to buy) | −4,474 | 0 | ||
| 2017-05-30 | Gullans Steven R. Ph.D. Interim President & CEO | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2017-03-28 | Golden Lee Scott Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-03-10 | SASSINE ANDY Director | Purchase | +21,119 | $9.47 | $200K | 136,264 |
| 2017-03-10 | SASSINE ANDY Director | Purchase · Warrant to Purchase Common Stock | +15,840 | $9.47 | $150K | 15,840 |
| 2017-03-10 | LICHTINGER PEDRO Director | Purchase | +10,559 | $9.47 | $100K | 59,833 |
| 2017-03-10 | LICHTINGER PEDRO Director | Purchase · Warrant to Purchase Common Stock | +7,920 | $9.47 | $75K | 7,920 |
| 2017-03-10 | Hawryluk P. Kent Director | Purchase | +25,000 | $9.47 | $237K | 81,889 |
| 2017-03-10 | Hawryluk P. Kent Director | Purchase · Warrant to Purchase Common Stock | +18,750 | $9.47 | $178K | 18,750 |
| 2017-03-10 | Gullans Steven R. Ph.D. Director | Purchase | +52,798 | $9.47 | $500K | 858,823 |
| 2017-03-10 | Gullans Steven R. Ph.D. Director | Purchase · Warrant to Purchase Common Stock | +39,599 | $9.47 | $375K | 39,599 |
| 2017-02-01 | KOUSKY KENNETH W Director | Other disposition | −101,406 | 4,472 | ||
| 2017-02-01 | KOUSKY KENNETH W Director | Other disposition | −110,428 | 6,463 | ||
| 2016-11-25 | Sooch Mina President & CEO | Grant or award · Employee Stock Option (right to buy) | +120,000 | 600,000 | ||
| 2016-10-05 | Golden Lee Scott Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +126,000 | 126,000 |
Page 6 of 7 · 135 trades